|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
|---|---|
| Information provided by: | National Institutes of Health Clinical Center (CC) |
| ClinicalTrials.gov Identifier: | NCT00001420 |
Purpose
This study will examine the genetic and immune factors involved in the cause and development of psoriatic arthritis-a disease of both the skin and joints. It will describe the medical features and natural course of the disease and determine participants' eligibility for experimental treatment protocols.
Patients with known or suspected psoriatic arthritis 5 years of age and older and their relatives may enroll in this study. Patients will be evaluated with a medical history and physical examination, electrocardiogram, blood tests and X-rays. Additional procedures may include:
Patients will be followed once or twice a year and may be evaluated for participation in an experimental treatment study.
Participating relatives of patients will fill out a brief medical history questionnaire and provide a DNA sample (blood sample or tissue swab from the inside of the cheek).
| Condition |
|---|
|
Psoriasis Psoriatic Arthritis |
| Study Type: | Observational |
| Official Title: | Studies of the Pathogenesis and Natural History of Psoriatic Arthritis |
| Estimated Enrollment: | 999 |
| Study Start Date: | March 1995 |
| Estimated Study Completion Date: | January 2006 |
Patients with known or suspected psoriatic arthritis will be evaluated at the Clinical Center. Studies will include characterization of the clinical and laboratory features of the disease, research studies of the natural history and pathogenesis, genetic studies, and determination of the patient's eligibility to enter experimental therapeutic protocols. Patients may be asked to contribute blood, skin or synovial membrane samples for immunologic and genetic research studies.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
INCLUSION CRITERIA:
Psoriatic arthritis (proven or suspected) or;
Family history of psoriasis or psoriatic arthritis (i.e. family members of patients with psoriasis or psoriatic arthritis); and
Willingness and ability of the subject or guardian to give informed consent.
EXCLUSION CRITERIA:
Concomitant medical problems which would confound the interpretation of immunological studies.
Concomitant medical, surgical or other conditions for which inadequate facilities or funds are available to support their care at the NIH.
Contacts and Locations
More Information
| Study ID Numbers: | 950082, 95-AR-0082 |
| Study First Received: | November 3, 1999 |
| Last Updated: | March 3, 2008 |
| ClinicalTrials.gov Identifier: | NCT00001420 History of Changes |
| Health Authority: | United States: Federal Government |
|
Lymphocytes Cytokines Apoptosis |
Psoriasis Genetics Psoriatic Arthritis |
|
Spinal Diseases Skin Diseases Musculoskeletal Diseases Psoriasis Arthritis, Psoriatic Joint Diseases |
Arthritis Skin Diseases, Papulosquamous Bone Diseases Spondylarthritis Spondylarthropathies |